Thurston Springer Miller Herd & Titak Inc. Has $1.74 Million Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Thurston Springer Miller Herd & Titak Inc. increased its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 64.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,921 shares of the biotechnology company's stock after acquiring an additional 1,140 shares during the period. Thurston Springer Miller Herd & Titak Inc.'s holdings in Axon Enterprise were worth $1,736,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. DekaBank Deutsche Girozentrale grew its holdings in shares of Axon Enterprise by 32.2% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 22,450 shares of the biotechnology company's stock worth $6,689,000 after acquiring an additional 5,464 shares during the period. Thoroughbred Financial Services LLC purchased a new position in Axon Enterprise during the second quarter worth about $368,000. Envestnet Asset Management Inc. lifted its holdings in shares of Axon Enterprise by 12.0% during the 2nd quarter. Envestnet Asset Management Inc. now owns 79,908 shares of the biotechnology company's stock worth $23,512,000 after acquiring an additional 8,575 shares during the period. J.W. Cole Advisors Inc. acquired a new stake in shares of Axon Enterprise in the second quarter worth approximately $366,000. Finally, Thompson Siegel & Walmsley LLC purchased a new stake in Axon Enterprise in the second quarter valued at approximately $273,000. Institutional investors and hedge funds own 79.08% of the company's stock.

Insider Activity

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 21,834 shares of the business's stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the sale, the insider now directly owns 154,394 shares of the company's stock, valued at $91,691,508.72. The trade was a 12.39 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the sale, the director now directly owns 6,929 shares of the company's stock, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 50,545 shares of company stock valued at $30,721,337. Company insiders own 6.10% of the company's stock.

Wall Street Analysts Forecast Growth

AXON has been the topic of a number of research analyst reports. The Goldman Sachs Group lifted their target price on Axon Enterprise from $385.00 to $441.00 and gave the company a "buy" rating in a report on Wednesday, October 23rd. TD Cowen started coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price target for the company. Morgan Stanley raised Axon Enterprise from an "equal weight" rating to an "overweight" rating and upped their target price for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Needham & Company LLC raised their target price on Axon Enterprise from $525.00 to $600.00 and gave the company a "buy" rating in a report on Friday, November 8th. Finally, JMP Securities increased their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a "market outperform" rating in a research report on Thursday, October 31st. One investment analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company's stock. Based on data from MarketBeat, Axon Enterprise has an average rating of "Moderate Buy" and a consensus target price of $504.92.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON traded up $2.07 during trading on Wednesday, reaching $581.87. The stock had a trading volume of 184,808 shares, compared to its average volume of 630,699. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The stock has a market cap of $44.37 billion, a PE ratio of 150.35, a P/E/G ratio of 14.19 and a beta of 1.04. Axon Enterprise, Inc. has a one year low of $246.99 and a one year high of $698.67. The firm's 50 day moving average price is $612.80 and its two-hundred day moving average price is $454.94.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.